Intensive Clotting Factor Prophylaxis Does Not Prevent Severe PPH in VWD – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Anne de Vaan et al, adding:
”Higher-Dosed Clotting Factor Prophylaxis Fails to Reduce Postpartum Hemorrhage in Women With von Willebrand Disease
A prospective Dutch study found that intensified prophylactic clotting factor therapy during pregnancy did not reduce severe postpartum hemorrhage rates in women with von Willebrand disease.”
Title: Higher-dosed clotting factor prophylaxis fails to reduce postpartum hemorrhage in women with von Willebrand disease: findings from the observational PRegnancy and Inherited bleeding DisordErS study
Authors: Anne de Vaan, Jeroen Eikenboom, Marieke Kruip, Marieke Punt, Saskia Schols, Floor Heubel-Moenen, Michiel Coppens, Laurens Nieuwenhuizen, Anja Mäkelburg, Marjolein Peters, Hans Duvekot, Annemieke Middeldorp, Kitty Bloemenkamp, Roger Schutgens, Titia Lely, Karin van Galen
Read the Full Article on JTH

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough
-
Oct 20, 2026, 14:39Jan Hartmann: How Hemophilia Care Has Advanced Over the Past Decade
-
Oct 20, 2026, 14:27Amna Jamalallail: SCD and Thalassemia in Jeddah – A Public Health Perspective
-
Oct 20, 2026, 14:14Advancing Thalassaemia and Sickle Cell Care Through Nordic Collaboration – TIF
-
Oct 20, 2026, 14:01Ashkan Forouzani։ Warfarin or DOACs in Protein C and S Deficiency?
-
Oct 20, 2026, 13:20The Global Blood Crisis – Are We Solving the Wrong Problem?
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population